Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Approves Japanese Lower-Body Exoskeleton

Cyberdyne’s Hybrid Assistive Limb is a robotic device that helps people with lower limb disabilities walk on their own.

Cyberdyne's HAL / Image: Cyberdyne
Cyberdyne's HAL / Image: Cyberdyne

A recent article from IEEE Spectrum reported on the FDA’s approval of a medical device that increases the mobility of people with lower limb disabilities. The robotic device, known as HAL (Hybrid Assistive Limb), is a lower-body exoskeleton that is strapped to the user’s legs and increases their strength by a factor of up to ten. HAL’s sensors detect bioelectric signals from the brain that instruct it to power up and assist in moving.

The FDA approved a specific version of Cyberdyne’s robot called HAL for Medical Use, which will be sold in the United States via licensed medical facilities. It has been available in Japan for several years; a video of HAL in use can be seen here.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report